This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Jagdishwar Sahay Srivastava: Innovator in Pharmaceutical Sciences
Introduction
Jagdishwar Sahay Srivastava is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel drug formulations. His work focuses on improving the efficacy and safety of opioid peptides, which are crucial in pain management.
Latest Patents
One of his key patents is titled "Inclusion complexes of a high potent opioid peptide, pharmaceutical compositions and method of treatment." This invention provides novel inclusion complexes of a highly potent opioid peptide, L-Tyrosyl-D-alanyl-glycyl-N-methylphenylalanyl-glycyl-isopropylamide, with cyclodextrin. The pharmaceutical preparations containing these inclusion complexes demonstrate improved solubility in water and enhanced biopharmaceutical properties. These properties include reduced toxicity, better analgesic action, and non-addiction characteristics, making them a valuable advancement in pain management therapies.
Career Highlights
Jagdishwar Sahay Srivastava is associated with the Council of Scientific and Industrial Research, where he has been instrumental in various research initiatives. His innovative approach to drug formulation has garnered attention in the scientific community, contributing to advancements in pharmaceutical technology.
Collaborations
He has collaborated with esteemed colleagues such as Anil Kumar Dwivedi and Madhu Khanna, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Jagdishwar Sahay Srivastava's contributions to pharmaceutical sciences, particularly through his innovative patent, highlight his commitment to improving healthcare solutions. His work continues to influence the field and offers promising advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
